z-logo
Premium
Post‐burn alterations in cardiac Erk1/2 signaling (850.4)
Author(s) -
Guillory Ashley,
El Ayadi Amina,
Herndon David,
Finnerty Celeste
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.850.4
Subject(s) - phosphorylation , protein kinase b , western blot , signal transduction , burn injury , kinase , medicine , endocrinology , catecholamine , total body surface area , apoptosis , extracellular , chemistry , biology , microbiology and biotechnology , surgery , biochemistry , gene
. Severe burn trauma causes a catecholamine surge that has been demonstrated, in pediatric patients, to last up to 3 years post injury. The detrimental cardiac effects of the catecholamine surge include a reduction of functional β‐adrenergic receptors (β‐AR) and alterations in various signaling pathways such as that of extracellular signal regulated kinase (Erk1/2). Methods. We used a rat model of 60% total body surface area burn to investigate burn‐induced changes in cardiac signaling pathways. Animals were sacrificed and hearts were isolated 24 hrs and 7 days post injury. The expression and phosphorylation of proteins involved in Erk1/2 signaling were examined via Western Blot. Results. β 1 ‐AR expression levels were significantly increased 24 hrs post‐burn (p=0.009) but returned to control levels by 7 days post‐burn. No changes were observed in β 2 ‐AR expression levels. G i expression was initially depressed post‐burn but was increased at 7 days post‐burn (p=0.0009). Similarly, Erk1/2 phosphorylation was increased by 7 days post‐burn (p=0.036). However, Akt phosphorylation was decreased at 7 days post‐burn (p=0.01). Conclusion. These data indicate that burn injury alters Erk1/2 activation and activity, which may promote pro‐hypertrophic and pro‐apoptotic signaling. Furthermore, in the long‐term, these changes may underlie burn induced cardiac dysfunction and subsequent mortality. Grant Funding Source : Supported by grants from the NIH (P50‐GM60338, KL2RR029875,UL1RR029876) and SHC (80100, 71001).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom